# Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction

> **NCT04826497** · PHASE4 · UNKNOWN · sponsor: **Xuzhou Central Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** nicorandil
- **DRUG:** Placebo（normal saline）

## Key facts

- **NCT ID:** NCT04826497
- **Lead sponsor:** Xuzhou Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04
- **Primary completion:** 2021-12
- **Final completion:** 2022-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826497, "Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04826497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*